Total Value
$644.62B
Holdings Count
15
Period of Report
Mar 31, 2025
Report Type
HR
| Issuer | CUSIP | Value | Shares |
|---|---|---|---|
| AXSOME THERAPEUTICS INC | 05464T104 | $95.07B | 815,176 |
| APOGEE THERAPEUTICS INC | 03770N101 | $76.54B | 2,048,647 |
| SPYRE THERAPEUTICS INC | 00773J202 | $64.83B | 4,018,101 |
| ENLIVEN THERAPEUTICS INC | 29337E102 | $63.03B | 3,202,798 |
| NUVALENT INC | 670703107 | $51.60B | 727,563 |
| DIANTHUS THERAPEUTICS INC | 252828108 | $48.99B | 2,700,691 |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | $46.45B | 3,445,813 |
| SCHOLAR ROCK HLDG CORP | 80706P103 | $44.18B | 1,374,031 |
| COGENT BIOSCIENCES INC | 19240Q201 | $37.29B | 6,225,641 |
| ORUKA THERAPEUTICS INC | 687604108 | $34.60B | 3,371,922 |
| KINIKSA PHARMACEUTICALS INTL | G52694109 | $24.48B | 1,102,248 |
| ASTRIA THERAPEUTICS INC | 04635X102 | $18.98B | 3,554,129 |
| ZENAS BIOPHARMA INC | 98937L105 | $14.95B | 1,892,806 |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | $13.41B | 6,125,000 |
| BICARA THERAPEUTICS INC | 055477103 | $10.22B | 784,170 |